Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Jul;6(7):e481-e492.
doi: 10.1016/S2665-9913(24)00022-5. Epub 2024 Apr 1.

Proliferative features of IgG4-related disease

Affiliations
Review

Proliferative features of IgG4-related disease

Guy Katz et al. Lancet Rheumatol. 2024 Jul.

Abstract

IgG4-related disease is an immune-mediated disease that can lead to substantial morbidity and organ damage. Capable of affecting nearly any organ system or anatomic site, and showing considerable overlap in clinical presentation with various other diseases, IgG4-related disease often poses a diagnostic challenge for clinicians. Furthermore, there are no diagnostic biomarkers with high specificity for IgG4-related disease, and histopathological examination is nuanced and requires clinical correlation for accurate diagnosis. Therefore, it is crucial for clinicians to recognise the clinical phenotypes of IgG4-related disease. The disease is generally considered to have predominantly fibrotic and proliferative (or inflammatory) manifestations, with distinct clinical, serological and histopathological findings associated with each manifestation. However, the fibrotic and proliferative manifestations of this disease frequently occur together, thereby blurring this dichotomous distinction. In this Series paper, we provide a detailed overview of the clinical manifestations typical of the proliferative features of IgG4-related disease, with an emphasis on the diagnostic evaluation and differential diagnosis of each proliferative disease manifestation. In addition, we summarise the immune mechanisms underlying IgG4-related disease, suggest a framework for how to approach management and monitoring after the diagnosis is established, and highlight current unmet needs for patient care surrounding this disease.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests GK receives research support from Sanofi. YH-B receives research support from Nestlé Health Science and PACT-CP Registry; payment or honoraria for lectures or presentations from Mayo Clinic CME course, Mount Sinai Hospital, and Washington University (in St Louis); and is a member of the Scientific Advisory Board of Nestlé Health Science. DP discloses a grant from Ministero Italiano della Salute (GR-2021-12373600). CAP receives research support from Horizon Therapeutics and Sanofi. All other authors declare no competing interests.

Similar articles

Cited by

MeSH terms

Substances

LinkOut - more resources